Clinical study of poorly differentiated head and neck squamous cell carcinoma: a prospective cohort study in China

被引:2
|
作者
Ding, Shuo [1 ]
Guo, Wei [1 ]
Yin, Gaofei [1 ]
Li, Nuan [1 ]
Liu, Hongfei [1 ]
Huang, Junwei [1 ]
Yang, Zheng [1 ]
Xu, Hongbo [1 ]
Chen, Xiaohong [1 ]
Zhang, Yang [1 ]
Huang, Zhigang [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Squamous cell carcinoma of head and neck; clinical pathology; clinical protocols; SURVIVAL; CANCER;
D O I
10.21037/atm-22-2630
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although poorly differentiated is rare in head and neck squamous cell carcinoma (HNSCC), its prognosis are worse with high rate of local recurrence and distant metastasis (DS). Therefore, this study hopes to carry out prospective clinical research on different treatment options for poorly differentiated patients and explore the treatment scheme more suitable for these patients. Methods: This study is a prospective cohort study. We selected patients with poorly differentiated carcinoma in larynx or hypopharynx (stage I-IV, T1-4a, N0-2, M0). The intervention treatment methods for stage I-II patients are as follows: surgery, induction chemotherapy (IC) + surgery; surgery + adjuvant therapy; The intervention treatment methods for stage III-IV patients are as follows: surgery, IC + surgery + adjuvant therapy, surgery + adjuvant therapy. The patients were followed up for at least 1 year, and the disease progression and survival were counted. Results: From September 2016 to October 2020, 62 patients were included (29 patients in stage I/II and 33 patients in stage III/IV). We found that there was no significant difference in survival between treatment groups in stage I/II patients [overall survival (OS): P=0.447; progression free survival (PFS): P=0.504], but the surgery + adjuvant treatment group had a significant advantage in 3-year OS (100%). In stage III/IV patients, there were significant differences in DS, OS and PFS between different treatment groups (DS: P=0.013; OS: P=0.021; PFS: P=0.020). Among them, the survival rate of IC + surgery + adjuvant treatment group was the best, with 3-year OS of 78%. Conclusions: Our study found that postoperative radiotherapy may improve the OS rate of patients with early (stage I/II) poorly differentiated HNSCC; For advanced patients (stage III/IV), surgery combined with IC and postoperative adjuvant radiotherapy may better control DS and improve the survival rate. However, our study draws the above conclusions based on small sample data, and we will continue to summarize and expand the sample size for verification.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Narrow band imaging versus autofluorescence imaging for head and neck squamous cell carcinoma detection: a prospective study
    Ni, X-G
    Zhang, Q-Q
    Wang, G-Q
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 (11): : 1001 - 1006
  • [32] Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck
    Shirai, Katsuyuki
    Saitoh, Jun-ichi
    Musha, Atsushi
    Abe, Takanori
    Kobayashi, Daijiro
    Takahashi, Takeo
    Tamaki, Tomoaki
    Kawamura, Hidemasa
    Takayasu, Yukihiro
    Shino, Masato
    Toyoda, Minoru
    Takahashi, Katsumasa
    Hirato, Junko
    Yokoo, Satoshi
    Chikamatsu, Kazuaki
    Ohno, Tatsuya
    Nakano, Tatsuya
    [J]. CANCER SCIENCE, 2017, 108 (10) : 2039 - 2044
  • [33] Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study
    Gong, E. J.
    Kim, D. H.
    Ahn, J. Y.
    Choi, K. -S.
    Jung, K. W.
    Lee, J. H.
    Choi, K. D.
    Song, H. J.
    Lee, G. H.
    Jung, H. -Y.
    Kim, J. H.
    Roh, J. -L.
    Choi, S. -H.
    Nam, S. Y.
    Kim, S. Y.
    [J]. DISEASES OF THE ESOPHAGUS, 2016, 29 (07) : 752 - 759
  • [34] Head and neck squamous cell carcinoma
    不详
    [J]. Nature Reviews Disease Primers, 6 (1)
  • [35] Clinical Impact of Screening for Head and Neck Region and Intervention for Early Head and Neck Squamous Cell Carcinoma in Patients With Esophageal Squamous Cell Carcinoma
    Morimoto, Hiroyuki
    Yano, Tomonori
    Yoda, Yusuke
    Satake, Hironaga
    Yagishita, Atsushi
    Kojima, Takashi
    Oono, Yasuhiro
    Ikematsu, Hiroaki
    Kaneko, Kazuhiro
    [J]. GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 468 - 469
  • [36] Squamous cell carcinoma in the head and neck
    Al-Reefy, Hiba
    Dhar, Vikrain
    Dilkes, Mike
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (07) : 380 - 383
  • [37] HEAD AND NECK SQUAMOUS CELL CARCINOMA
    不详
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01):
  • [38] Squamous cell carcinoma of the head and neck
    Lorenz, K. J.
    Maier, H.
    [J]. HNO, 2008, 56 (04) : 402 - 409
  • [39] Spindle Cell Squamous Cell Carcinoma of Head and Neck Region: a Clinicopathological and Immunohistochemical Study
    Neha, Bakshi
    Shashi, Dhawan
    Seema, Rao
    [J]. INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (04) : 699 - 705
  • [40] Spindle Cell Squamous Cell Carcinoma of Head and Neck Region: a Clinicopathological and Immunohistochemical Study
    Bakshi Neha
    Dhawan Shashi
    Rao Seema
    [J]. Indian Journal of Surgical Oncology, 2021, 12 : 699 - 705